The clinical presentation of preeclampsia is preceded by elevated circulating sFLT1 (soluble fms-like tyrosine kinase-1) and decreased PlGF (placenta growth factor)—a proangiogenic and proendothelial growth factor that is bound and inactivated by sFLT1. This evidence concerns the gene FLT1 and preeclampsia.